Ontology highlight
ABSTRACT: Introduction
Small-scale clinical studies with psychedelic drugs have shown promising results for the treatment of several mental disorders. Before psychedelics become registered medicines, it is important to know the full range of adverse events (AEs) for making balanced treatment decisions.Objective
To systematically review the presence of AEs during and after administration of serotonergic psychedelics and 3,4-methyenedioxymethamphetamine (MDMA) in clinical studies.Methods
We systematically searched PubMed, PsycINFO, Embase, and ClinicalTrials.gov for clinical trials with psychedelics since 2000 describing the results of quantitative and qualitative studies.Results
We included 44 articles (34 quantitative + 10 qualitative), describing treatments with MDMA
SUBMITTER: Breeksema JJ
PROVIDER: S-EPMC9548934 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature